94 related articles for article (PubMed ID: 18496862)
1. Human osteoclast formation and activity on a xenogenous bone mineral.
Perrotti V; Nicholls BM; Horton MA; Piattelli A
J Biomed Mater Res A; 2009 Jul; 90(1):238-46. PubMed ID: 18496862
[TBL] [Abstract][Full Text] [Related]
2. In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation: a pilot study.
Taylor JC; Cuff SE; Leger JP; Morra A; Anderson GI
Int J Oral Maxillofac Implants; 2002; 17(3):321-30. PubMed ID: 12074446
[TBL] [Abstract][Full Text] [Related]
3. Human osteoclast formation and activity on an equine spongy bone substitute.
Perrotti V; Nicholls BM; Piattelli A
Clin Oral Implants Res; 2009 Jan; 20(1):17-23. PubMed ID: 19126103
[TBL] [Abstract][Full Text] [Related]
4. Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene.
Matsuzaki K; Katayama K; Takahashi Y; Nakamura I; Udagawa N; Tsurukai T; Nishinakamura R; Toyama Y; Yabe Y; Hori M; Takahashi N; Suda T
Endocrinology; 1999 Feb; 140(2):925-32. PubMed ID: 9927325
[TBL] [Abstract][Full Text] [Related]
5. Formation of osteoclast-like cells from peripheral blood of periodontitis patients occurs without supplementation of macrophage colony-stimulating factor.
Tjoa ST; de Vries TJ; Schoenmaker T; Kelder A; Loos BG; Everts V
J Clin Periodontol; 2008 Jul; 35(7):568-75. PubMed ID: 18435789
[TBL] [Abstract][Full Text] [Related]
6. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the ability of chondroitin sulfate derived from bovine, fish and pigs to suppress human osteoclast activity in vitro.
Cantley MD; Rainsford KD; Haynes DR
Inflammopharmacology; 2013 Dec; 21(6):407-12. PubMed ID: 23644893
[TBL] [Abstract][Full Text] [Related]
8. Targeting MEK1/2 blocks osteoclast differentiation, function and cytokine secretion in multiple myeloma.
Breitkreutz I; Raab MS; Vallet S; Hideshima T; Raje N; Chauhan D; Munshi NC; Richardson PG; Anderson KC
Br J Haematol; 2007 Oct; 139(1):55-63. PubMed ID: 17854307
[TBL] [Abstract][Full Text] [Related]
9. M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase.
Glantschnig H; Fisher JE; Wesolowski G; Rodan GA; Reszka AA
Cell Death Differ; 2003 Oct; 10(10):1165-77. PubMed ID: 14502240
[TBL] [Abstract][Full Text] [Related]
10. Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties.
Chu K; Snyder R; Econs MJ
J Bone Miner Res; 2006 Jul; 21(7):1089-97. PubMed ID: 16813529
[TBL] [Abstract][Full Text] [Related]
11. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures.
Matsuzaki K; Udagawa N; Takahashi N; Yamaguchi K; Yasuda H; Shima N; Morinaga T; Toyama Y; Yabe Y; Higashio K; Suda T
Biochem Biophys Res Commun; 1998 May; 246(1):199-204. PubMed ID: 9600092
[TBL] [Abstract][Full Text] [Related]
12. Multinucleated giant cells with an osteoclast phenotype derived from caprine peripheral blood mononuclear cells.
Pisoni G; D'Amelio P; Sassi F; Manarolla G; Scaccabarozzi L; Locatelli C; Mazzocchi N; Baruscotti M; DiFrancesco D; Moroni P
Vet J; 2011 Sep; 189(3):361-3. PubMed ID: 20822938
[TBL] [Abstract][Full Text] [Related]
13. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.
Jimi E; Akiyama S; Tsurukai T; Okahashi N; Kobayashi K; Udagawa N; Nishihara T; Takahashi N; Suda T
J Immunol; 1999 Jul; 163(1):434-42. PubMed ID: 10384146
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
15. Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts.
Reddy SV; Kurihara N; Menaa C; Landucci G; Forthal D; Koop BA; Windle JJ; Roodman GD
Endocrinology; 2001 Jul; 142(7):2898-905. PubMed ID: 11416009
[TBL] [Abstract][Full Text] [Related]
16. Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein.
Weir EC; Lowik CW; Paliwal I; Insogna KL
J Bone Miner Res; 1996 Oct; 11(10):1474-81. PubMed ID: 8889847
[TBL] [Abstract][Full Text] [Related]
17. A novel culture system to generate osteoclasts and bone resorption using porcine bone marrow cells: role of M-CSF.
Scheven BA; Milne JS; Robins SP
Biochem Biophys Res Commun; 1997 Feb; 231(1):231-5. PubMed ID: 9070255
[TBL] [Abstract][Full Text] [Related]
18. Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity.
Ang ES; Pavlos NJ; Chai LY; Qi M; Cheng TS; Steer JH; Joyce DA; Zheng MH; Xu J
J Cell Physiol; 2009 Dec; 221(3):642-9. PubMed ID: 19681045
[TBL] [Abstract][Full Text] [Related]
19. Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor.
Nicholls BM; Bredius RG; Hamdy NA; Gerritsen EJ; Lankester AC; Hogendoorn PC; Nesbitt SA; Horton MA; Flanagan AM
J Bone Miner Res; 2005 Dec; 20(12):2264-70. PubMed ID: 16294279
[TBL] [Abstract][Full Text] [Related]
20. Generation of human osteoclasts from peripheral blood.
Henriksen K; Karsdal MA; Taylor A; Tosh D; Coxon FP
Methods Mol Biol; 2012; 816():159-75. PubMed ID: 22130928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
